Connor, Clark & Lunn Investment Management Ltd. Outset Medical, Inc. Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $21.8 Billion
- Q1 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Outset Medical, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 345,343 shares of OM stock, worth $1.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
345,343Holding current value
$1.33 Million% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding OM
# of Institutions
122Shares Held
41MCall Options Held
63.4KPut Options Held
32.1K-
Ameriprise Financial Inc Minneapolis, MN5.11MShares$19.7 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.01MShares$15.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$12.6 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY3.11MShares$12 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$11.1 Million0.0% of portfolio
About Outset Medical, Inc.
- Ticker OM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 48,007,300
- Market Cap $185M
- Description
- Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...